Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
BCLI
$0.84
-28.21%
BCLI
· Brainstorm Cell Therapeutics Inc.
$0.84
-0.33 (-28.21%)
At close · Jul 18
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Such conditions raise substantial doubts about the Company’s ability to continue as a going concern. Management’s plan includes raising funds from outside potential investors, however, as mentioned above, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives.”View the 10-Q filed Aug 14, 2026
Market Cap
$10.81M
Shares
11.03M
Volume · Jul 18
819.7K
Avg daily vol (3M)
1.39M
All webcasts
Earnings call · FY2024 Q3
Brainstorm Cell Therapeutics Inc. (BCLI) Q3 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$0.51
Net income
-$2.71M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 14, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 14, 2024 · complete as-filed document